Your browser doesn't support javascript.
loading
Dual nanoenzymes loaded hollow mesoporous organotantalum nanospheres for chemo-radio sensitization.
Peng, Chao; Liang, Yu; Su, Ning; Chen, Siwen; Yuan, Zhen; Chen, Yanqun; Wu, Dong; Wu, Bin; Zhang, Yang; Xu, ZiTing; Zheng, Si; Li, Yingjia; Zhao, Bingxia.
Afiliação
  • Peng C; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Department of Cerebrov
  • Liang Y; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Su N; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Chen S; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Yuan Z; Faculty of Health Sciences, University of Macau, Macau 999078, China.
  • Chen Y; Department of Oncology, Kiang Wu Hospital, Macau 999078, China.
  • Wu D; Institute of Respiratory Diseases, Department of Respiratory, The Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.
  • Wu B; Institute of Respiratory Diseases, Department of Respiratory, The Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.
  • Zhang Y; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Xu Z; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Zheng S; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Li Y; Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Electronic address: lyjia@smu.edu.cn.
  • Zhao B; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, Chin
J Control Release ; 347: 369-378, 2022 07.
Article em En | MEDLINE | ID: mdl-35577149
Chemo-radiotherapy has been extensively used in clinics, displaying substantial advantages in treatment and prognosis. Stimuli-responsive biodegradable nanoagents that can achieve not only delivery and controlled release of chemotherapeutics, but also hypoxia alleviation to enhance chemoradiotherapy therefore has tremendous potential. Herein, glutathione (GSH)-responsive, biodegradable, doxorubicin-carrying hollow mesoporous organotantalum nanospheres modified with Au and Pt dual nanoenzymes (HMOTP@Pt@Au@Dox) were constructed for chemo-radio sensitization. Degradation of HMOTP@Pt@Au@Dox can be self-activated through GSH stimulation and on-demand release packaged Dox owing to the disulfide bond in the hybrid framework of organotantalum nanospheres. Au and Pt nanoenzymes triggered cascade catalytic reactions that could alleviate hypoxia by utilizing ß-d-glucose and H2O2, thereby sensitizing ROS-based chemoradiotherapy with synergistic starving therapy. Given the radiosensitization of high-Z elements (Ta, Pt, Au), nanoenzymes induced cascade catalytic reaction for hypoxia relief, and the depletion of the predominant antioxidant GSH, desirable tumor suppression could be achieved both in vitro and in vivo, indicating that HMOTP@Pt@Au@Dox is a promising nanoagent to boost chemo-radiotherapy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Nanosferas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Nanosferas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article